Fourth branchial anomalies: Predictive factors of therapeutic success
Marie‐Eva Rossi(Aix-Marseille Université), Françoise Denoyelle(Hôpital Necker-Enfants Malades), Jean‐Michel Triglia(Hôpital de la Timone), M. Akkari(Hôpital Gui de Chauliac), M. Mondain, R. Nicollas(Hôpital de la Timone), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Éric Moreddu(Assistance Publique Hôpitaux de Marseille)
Cited by 10
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
|PEDIATRICS|2015|113
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110